Health ❯ Healthcare ❯ Chronic Conditions

Type 2 Diabetes

Management Strategies Weight Loss Medications Medication Management GLP-1 Receptor Agonists Monitoring and Management Treatment Options GLP-1 Drug Usage Medication Treatments Weight Management Insulin Sensitivity Obesity Management Diabetes Management GLP-1 Drugs GLP-1 Medications Obesity and Diabetes Management and Treatment GLP-1 Agonists Atherosclerotic Cardiovascular Disease Obesity Medication Usage CagriSema Treatment Semaglutide Use Medication Access

Novo Nordisk Files FDA Application for Weekly CagriSema Obesity Shot as GLP-1 Competition Intensifies

The filing positions a potential 2026 FDA review for what could be the first fixed‑dose GLP‑1 and amylin combination therapy.

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies